Swarm Oncology
PrivateLast Round
Seed
Mar 5, 2026
Total Funding Raised
$10.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Swarm Oncology operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2026.
Swarm Oncology is a biotechnology company that develops personalized T-cell therapies designed to treat advanced solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swarm Oncology Comparables
Compare Swarm Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Recursion Pharmaceuticals | 74% | |
| T-Therapeutics | 66% | |
| KSQ Therapeutics | 66% |
For institutional investors. Book with your work email.
Swarm Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 5, 2026 | ||||
| Grant | Sep 25, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Swarm Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 360% MoM.
- Mar 5, 2026
$8.2M round led by Delin Ventures
For institutional investors. Book with your work email.
Swarm Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Swarm Oncology's valuation, stock price, and market status.
Is Swarm Oncology a public or private company?
Swarm Oncology is a private company.
What is the current stock price of Swarm Oncology?
Swarm Oncology is a private company, so its shares have no public market price. Caplight tracks Swarm Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Swarm Oncology worth (valuation)?
Valuation information for Swarm Oncology is not publicly available.
Can I buy Swarm Oncology stock?
Swarm Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Swarm Oncology's last funding round?
Swarm Oncology's most recent funding round was Seed on March 5, 2026.
Who are the main investors in Swarm Oncology?
Key investors in Swarm Oncology include Delin Ventures.
Will Swarm Oncology IPO soon?
No public IPO plans have been announced for Swarm Oncology.
How can I track Swarm Oncology secondary market activity?
Caplight tracks bids, offers, and trades in Swarm Oncology's shares on secondary markets.